Skip to main content
. 2015 Jul 10;100(9):3380–3387. doi: 10.1210/JC.2015-1662

Table 3.

Multivariable Adjusted OR of Hip Fracture Based on Quartiles of TNF-sR1 and TNFsR2

n Q1a Q2a Q3a Q4a P for Trend
Model 1
    TNFα-sR1 396 1 1.77* (1.14, 2.74) 1.67* (1.09, 2.56) 2.27*** (1.45, 3.55) .0011
    TNFα-sR2 391 1 1.41 (0.91, 2.20) 1.48 (0.94, 2.31) 2.10*** (1.36, 3.24) .0010
Model 2
    TNFα-sR1 396 1 1.74* (1.07, 2.82) 1.86* (1.15, 2.98) 3.11*** (1.87, 5.17) <.0001
    TNFα-sR2 391 1 1.70* (1.03, 2.79) 1.61 (0.97, 2.65) 2.76*** (1.68, 4.51) .0001
Model 3
    TNFα-sR1 250 1 1.66 (0.84, 3.29) 1.73 (0.86, 3.48) 2.24* (1.05, 4.79) .0475
    TNFα-sR2 245 1 1.92 (0.92, 3.98) 1.91 (0.92, 3.97) 2.83** (1.34, 5.99) .0113

Data are expressed as OR (95% CI) obtained from logistic regression models. Quartile 1 is the reference stratum (OR = 1). “n” represents the number of case and control pairs used in the analysis; it varies due to missing covariate data. Model 1 is matched on age, race, year of enrollment, self-reported hormone use; no adjustment for other covariates. Model 2 is model 1 plus FRAX score. Model 3 is model 2 plus nutritional variables (intake of calcium, vitamin D, total energy, protein, multivitamin use), and factors impacting inflammation (NSAID use, arthritis, depression, body mass index, self-reported general health, comorbidity index, physical function, poor endurance/exhaustion, physical activity).

a

Interquartile cut-points for TNFα-sR1: 1246.0, 1465.2, and 1739.4 pg/mL; TNFα-sR2: 2674.4, 3118.4, and 3509.5 pg/mL (using controls only).

*

P < .05 relative to Q1;

**

P < .01;

***

P < .001. P values are from tests for linear trend.